🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Paul L. Chariou

ORCID: 0000-0002-7115-3878
MedicineAgricultural and Biological SciencesEnvironmental ScienceImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1–mediated tumor eradication”.

Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1–mediated tumor eradication

Journal of Clinical Investigation(2022)10.1172/jci155148
N/A
2.9DataRank · unranked
119 citations

Paul L. Chariou, Sofia R. Gameiro, Haiyan Qin, Masafumi Iida, Kristen Fousek +7 more

Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape

Nature Communications(2021)10.1038/s41467-021-25393-x
N/A
0DataRank · unranked
87 citations

Paul L. Chariou, Yohei Ozawa, Christine M. Minnar, Karin M. Knudson, Thomas J. Meyer +5 more

In situ vaccine application of inactivated CPMV nanoparticles for cancer immunotherapy

Materials Advances(2021)10.1039/d0ma00752h
N/A
0DataRank · unranked
35 citations

Veronique Beiss, Yifeng Ma, Nicole F. Steinmetz, Paul L. Chariou

Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients

ACS Nano(2020)10.1021/acsnano.0c00173
N/A
0DataRank · unranked
204 citations

Oscar A. Ortega‐Rivera, Nicole F. Steinmetz, Paul L. Chariou

Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004561
N/A
0DataRank · unranked
48 citations

Paul L. Chariou, Lucas A. Horn, Kristin C. Hicks, Claudia Palena, Jeffrey Schlom +2 more

Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03459-7
N/A
0DataRank · unranked
7 citations

Ginette S. Santiago-Sánchez, Kellsye P. Fabian, Kristen Solocinski, Paul L. Chariou, Duane H. Hamilton +6 more

Generation of murine tumor models refractory to αPD-1/-L1 therapies due to defects in antigen processing/presentation or IFNγ signaling using CRISPR/Cas9

PLoS ONE(2024)10.1371/journal.pone.0287733
N/A
0DataRank · unranked
2 citations

Christine M. Minnar, Mayank Tandon, Mary R. Guest, Raj Chari, Jeffrey Schlom +2 more